Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy

Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy

عرض إصدارات أخرى (1)

Background Androgen-deprivation therapy (ADT) is standard treatment for locally advanced or metastatic prostate cancer (PCa). Many patients develop castration resistance (castration-resistant PCa [CRPC]) after approximately 2-3 yr, with a poor prognosis. The molecular mechanisms underlying CRPC prog...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Rajan, P, Sudbery, I, Villasevil, M, Mui, E, Fleming, J, Davis, M, Ahmad, I, Edwards, J, Sansom, O, Sims, D, Ponting, C, Heger, A, McMenemin, R, Pedley, I, Leung, H
التنسيق: Journal article
اللغة:English
منشور في: Elsevier 2014

مواد مشابهة

مواد مشابهة